Future Tech: Almost Here, Round-the-corner Future Technology Podcast

David Freedman, a co-founder and the founding CEO of NanoView Biosciences, discusses noninvasive diagnostics and extracellular vesicles. Freedman was essential to NanoView’s entry into the expanding extracellular vesicle market with the development and subsequent launch of the ExoView R100. He has been a successful entrepreneur for more than ten years, formerly as CTO of eHomes, and President of a computer services company. Freedman is interested in commercialization strategy and organizational build-out, product and services development, tech engineering, as well as automation. Freedman completed his Ph.D. and Postdoc in Electrical Engineering at Boston University. NanoView Biosciences is at the leading edge of exosome discovery and they provide innovative solutions to detect and characterize extracellular vesicles. Freedman explains what extracellular vesicles are, for those who might not be familiar. As he states, extracellular vesicles are like the “Twitter of cells,” in that they are tiny messengers, p